Xenetic Biosciences (XBIO) Starts Presentation at LD Micro Main Event
Xenetic Biosciences (NASDAQ: XBIO) is a clinical-stage biopharmaceutical company that focuses on the discovery, development and planned commercialization of human drug therapies for the treatment of various conditions. Its drug delivery platform systems include PolyXen for creating next generation biologic drugs; OncoHist for the development of oncology drugs focused on orphan indications; Virexxa for the treatment of progesterone receptor negative endometrial cancer; and ImuXen for the development of vaccines that can simultaneously deliver multiple active pharmaceutical ingredients. For more information, visit the company's website at www.xeneticbio.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and…







